Stock Analysis, Dividends, Split History

EYES / Second Sight Medical Products, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)110.61
Enterprise Value ($M)110.61
Book Value ($M)6.54
Book Value / Share0.10
Price / Book18.24
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Stock Shares Outstanding 57,630,000
Common Shares Outstanding 59,858,842
Scoring Models
Piotroski F-Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-3.62
Return on Assets (ROA)-1.70
Return on Equity (ROE)-2.56
Balance Sheet (mrq) ($M)
Quick Ratio1.24
Current Ratio1.75
Income Statement (mra) ($M)
Sales Revenue Goods Net7,964,000.00
Operating Income-28.61
Net Income-28.52
Earnings Per Share Basic And Diluted-0.53
Cash Flow Statement (mra) ($M)
Cash From Operations-23.95
Cash from Investing2.84
Cash from Financing2.84
Identifiers and Descriptors
Central Index Key (CIK)1266806
Related CUSIPS
81362J118 81362J900 81362J950

Split History

Stock splits are used by Second Sight Medical Products, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related News Stories

Second Sight (EYES) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow

2018-09-06 seekingalpha
The following slide deck was published by Second Sight Medical Products in conjunction with this event. (2-2)

Insider Weekends - Director Of Andeavor Logistics Acquires $7.25 Million Worth Of Shares

2018-08-20 seekingalpha
Insider buying more than doubled last week with insiders purchasing $200.17 million of stock compared to $98 million in the week prior. Selling also increased with insiders selling $1.7 billion of stock last week compared to $1.51 billion in the week prior. (3-1)

Second Sight Medical Products (EYES): Moving Average Crossover Alert

2018-08-16 zacks
Second Sight Medical Products, Inc. (EYES - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for EYES broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness. (2-5)

Second Sight Medical Products, Inc. (EYES) CEO Jonathan McGuire on Q2 2018 Results - Earnings Call Transcript

2018-08-08 seekingalpha
Second Sight Medical Products, Inc. (NASDAQ:EYES) Q2 2018 Earnings Conference Call August 7, 2018 4:30 PM ET (2-1)

The Alfred E. Mann Foundation for Scientific Research is Pleased to Announce the Appointment of Robert Greenberg, MD, PhD to the Role of Executive Chairman

2018-06-27 accesswire
VALENCIA, CA / ACCESSWIRE / June 27, 2018 / The Alfred E. Mann Foundation for Scientific Research, ''AMF'', an independent non-profit medical device incubator committed to developing and commercializing innovative solutions for significant unmet or poorly met medical conditions, today announced the appointment of Robert Greenberg, MD, PhD to the role of Executive Chairman. ''I have enjoyed interacting with Dr. (180-0)

Second Sight Medical Products: Q1 Implant Results Disappoint

2018-05-11 seekingalpha
After 30 Argus II implants in Q4, the 16 implants in Q1 was weaker than expected. (65-1)

Second Sight Medical Products' (EYES) CEO Will McGuire on Q1 2018 Results - Earnings Call Transcript

2018-05-11 seekingalpha
Second Sight Medical Products (NASDAQ:EYES) Q1 2018 Earnings Conference Call May 10, 2018 4:30 PM ET (65-1)

CUSIP: 81362J100